Transient Pharma AB
559200-7875ActiveDeveloping peptide drugs targeting severe inflammatory diseases using natural templates.
Oversigt
- 0
- Medarbejdere
- 0 SEK
- Omsætning
- 2019
- Grundlagt
Nøglebeslutningstagere
Helene Hartman
CEO and Founder
Christian Kjellman
COO
Artur Schmidtchen
Founder and Board Member
Lena Mårtensson
Board Member
+4 flere kontakter i Funnelfeedr
Beskrivelse
Transient Pharma AB is a privately held, unlisted public company headquartered in Lund, Sweden. Their core mission is developing innovative treatments for diseases driven by excessive inflammation. The company leverages over 15 years of scientific research focused on Thrombin-derived C-terminal pept...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE559200787501
Beslutningstagere
8 kontakter i FunnelfeedrHelene Hartman
CEO and Founder
Christian Kjellman
COO
Artur Schmidtchen
Founder and Board Member
Lena Mårtensson
Board Member
Johan Jensen
Board Member
Bo Benell
Chairman of the Board
Andre kontakter
Anna-Karin Lindqvist
Team Member
Ganna Petruk
Senior Research Scientist
Lignende virksomheder
20 lignende virksomheder i FunnelfeedrPILA PHARMA AB
1–4 medarbejdereClinical stage biotech developing an oral obesity and diabetes treatment.
Truly Translational Sweden AB
1–4 medarbejdereAccelerating preclinical drug development through translational expertise and lab services.
Glimworks AB
5 medarbejdereDeveloping complex IT solutions via deep information architecture partnerships.
Truly Labs AB
20–49 medarbejdereAccelerating preclinical drug development through translational expertise and lab services.
AQILION AB
5–9 medarbejdereDeveloping innovative treatments for chronic inflammatory diseases via early-stage partnering.
Udforsk mere
Spørgsmål om Transient Pharma AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo